05:37 PM EST, 03/07/2024 (MT Newswires) -- Jeffrey Robert Ajer, Executive Vice President, Chief Commercial Officer, on March 05, 2024, sold 4,000 shares in Biomarin Pharmaceutical ( BMRN ) for $348,280. Following the Form 4 filing with the SEC, Ajer has control over a total of 94,047 shares of the company, with 94,047 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048477/000104847724000030/xslF345X03/wk-form4_1709850751.xml

Price: 87.98, Change: +2.09, Percent Change: +2.43